BofA Would Buy These 4 SMid Cap Biotechs on the Pullback
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad reiterated Buy ratings on Incyte (NASDAQ: INCY), argenx (NASDAQ: ARGX), Amicus Therapeutics (NASDAQ: FOLD) and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE